Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 23

1.

[A German version of the Cambridge examination for mental disorders of older people with Down's syndrome and others with intellectual disabilities : A diagnostic procedure for detecting dementia in people with Down's syndrome].

Nübling G, Loosli SV, Wlasich E, Prix C, Schönecker S, Freudelsperger L, Smrzka N, Strydom AM, Zaman SH, Benejam B, Missios J, Meister R, Danek A, Levin J.

Z Gerontol Geriatr. 2019 Aug 9. doi: 10.1007/s00391-019-01591-7. [Epub ahead of print] German.

PMID:
31399752
2.

Differential effects of Down's syndrome and Alzheimer's neuropathology on default mode connectivity.

Wilson LR, Vatansever D, Annus T, Williams GB, Hong YT, Fryer TD, Nestor PJ, Holland AJ, Zaman SH.

Hum Brain Mapp. 2019 Oct 15;40(15):4551-4563. doi: 10.1002/hbm.24720. Epub 2019 Jul 26.

PMID:
31350817
3.

Delineating the topography of amyloid-associated cortical atrophy in Down syndrome.

Mak E, Padilla C, Annus T, Wilson LR, Hong YT, Fryer TD, Coles JP, Aigbirhio FI, Menon DK, Nestor PJ, Zaman SH, Holland AJ.

Neurobiol Aging. 2019 Aug;80:196-202. doi: 10.1016/j.neurobiolaging.2019.02.018. Epub 2019 Mar 5.

PMID:
31207551
4.

Choroid Plexus Acts as Gatekeeper for TREM2, Abnormal Accumulation of ApoE, and Fibrillary Tau in Alzheimer's Disease and in Down Syndrome Dementia.

Raha-Chowdhury R, Henderson JW, Raha AA, Vuono R, Bickerton A, Jones E, Fincham R, Allinson K, Holland A, Zaman SH.

J Alzheimers Dis. 2019;69(1):91-109. doi: 10.3233/JAD-181179.

5.

Erythromyeloid-Derived TREM2: A Major Determinant of Alzheimer's Disease Pathology in Down Syndrome.

Raha-Chowdhury R, Henderson JW, Raha AA, Stott SRW, Vuono R, Foscarin S, Wilson L, Annus T, Fincham R, Allinson K, Devalia V, Friedland RP, Holland A, Zaman SH.

J Alzheimers Dis. 2018;61(3):1143-1162. doi: 10.3233/JAD-170814.

6.

Brain-predicted age in Down syndrome is associated with beta amyloid deposition and cognitive decline.

Cole JH, Annus T, Wilson LR, Remtulla R, Hong YT, Fryer TD, Acosta-Cabronero J, Cardenas-Blanco A, Smith R, Menon DK, Zaman SH, Nestor PJ, Holland AJ.

Neurobiol Aging. 2017 Aug;56:41-49. doi: 10.1016/j.neurobiolaging.2017.04.006. Epub 2017 Apr 18.

7.

The Early Presentation of Dementia in People with Down Syndrome: a Systematic Review of Longitudinal Studies.

Lautarescu BA, Holland AJ, Zaman SH.

Neuropsychol Rev. 2017 Mar;27(1):31-45. doi: 10.1007/s11065-017-9341-9. Epub 2017 Mar 13. Review.

8.

The Down syndrome brain in the presence and absence of fibrillar β-amyloidosis.

Annus T, Wilson LR, Acosta-Cabronero J, Cardenas-Blanco A, Hong YT, Fryer TD, Coles JP, Menon DK, Zaman SH, Holland AJ, Nestor PJ.

Neurobiol Aging. 2017 May;53:11-19. doi: 10.1016/j.neurobiolaging.2017.01.009. Epub 2017 Jan 17.

9.

Neuroprotective Effect of TREM-2 in Aging and Alzheimer's Disease Model.

Raha AA, Henderson JW, Stott SR, Vuono R, Foscarin S, Friedland RP, Zaman SH, Raha-Chowdhury R.

J Alzheimers Dis. 2017;55(1):199-217.

PMID:
27662313
10.

The pattern of amyloid accumulation in the brains of adults with Down syndrome.

Annus T, Wilson LR, Hong YT, Acosta-Cabronero J, Fryer TD, Cardenas-Blanco A, Smith R, Boros I, Coles JP, Aigbirhio FI, Menon DK, Zaman SH, Nestor PJ, Holland AJ.

Alzheimers Dement. 2016 May;12(5):538-45. doi: 10.1016/j.jalz.2015.07.490. Epub 2015 Sep 9.

11.

A neuroimaging proof of principle study of Down's syndrome and dementia: ethical and methodological challenges in intrusive research.

d'Abrera JC, Holland AJ, Landt J, Stocks-Gee G, Zaman SH.

J Intellect Disabil Res. 2013 Feb;57(2):105-18. doi: 10.1111/j.1365-2788.2011.01495.x. Epub 2011 Nov 2.

PMID:
22044507
12.

Using positron emission tomography and Carbon 11-labeled Pittsburgh Compound B to image Brain Fibrillar β-amyloid in adults with down syndrome: safety, acceptability, and feasibility.

Landt J, D'Abrera JC, Holland AJ, Aigbirhio FI, Fryer TD, Canales R, Hong YT, Menon DK, Baron JC, Zaman SH.

Arch Neurol. 2011 Jul;68(7):890-6. doi: 10.1001/archneurol.2011.36. Epub 2011 Mar 14.

PMID:
21403005
13.

Introduction of green fluorescent protein (GFP) into hippocampal neurons through viral infection.

Malinow R, Hayashi Y, Maletic-Savatic M, Zaman SH, Poncer JC, Shi SH, Esteban JA, Osten P, Seidenman K.

Cold Spring Harb Protoc. 2010 Apr;2010(4):pdb.prot5406. doi: 10.1101/pdb.prot5406.

14.

Women with autistic-spectrum disorder: magnetic resonance imaging study of brain anatomy.

Craig MC, Zaman SH, Daly EM, Cutter WJ, Robertson DM, Hallahan B, Toal F, Reed S, Ambikapathy A, Brammer M, Murphy CM, Murphy DG.

Br J Psychiatry. 2007 Sep;191:224-8.

PMID:
17766762
15.

Mutation of the GABAA receptor M1 transmembrane proline increases GABA affinity and reduces barbiturate enhancement.

Greenfield LJ Jr, Zaman SH, Sutherland ML, Lummis SC, Niemeyer MI, Barnard EA, Macdonald RL.

Neuropharmacology. 2002 Mar;42(4):502-21.

PMID:
11955521
16.

Long-term potentiation and changes seen in depression.

Zaman SH, Zaman R.

Br J Psychiatry. 2001 Dec;179:559-60. No abstract available.

PMID:
11731365
17.

Enhanced synaptic potentiation in transgenic mice expressing presenilin 1 familial Alzheimer's disease mutation is normalized with a benzodiazepine.

Zaman SH, Parent A, Laskey A, Lee MK, Borchelt DR, Sisodia SS, Malinow R.

Neurobiol Dis. 2000 Feb;7(1):54-63.

PMID:
10671322
18.

Rapid spine delivery and redistribution of AMPA receptors after synaptic NMDA receptor activation.

Shi SH, Hayashi Y, Petralia RS, Zaman SH, Wenthold RJ, Svoboda K, Malinow R.

Science. 1999 Jun 11;284(5421):1811-6.

19.

Unusual effects of benzodiazepines and cyclodiene insecticides on an expressed invertebrate GABAA receptor.

Zaman SH, Harvey RJ, Barnard EA, Darlison MG.

FEBS Lett. 1992 Aug 3;307(3):351-4.

20.

Effects of subunit types of the recombinant GABAA receptor on the response to a neurosteroid.

Zaman SH, Shingai R, Harvey RJ, Darlison MG, Barnard EA.

Eur J Pharmacol. 1992 Apr 10;225(4):321-30.

PMID:
1323476
21.

Sequence of a functional invertebrate GABAA receptor subunit which can form a chimeric receptor with a vertebrate alpha subunit.

Harvey RJ, Vreugdenhil E, Zaman SH, Bhandal NS, Usherwood PN, Barnard EA, Darlison MG.

EMBO J. 1991 Nov;10(11):3239-45.

22.

Endogenous steroids and pathogenesis of hepatic encephalopathy.

Zaman SH.

Lancet. 1990 Sep 1;336(8714):573-4. No abstract available.

PMID:
1975073
23.

Impact of pneumoconiosis on mining industry.

Zaman SH.

J Indian Med Assoc. 1969 Jun 16;52(12):549-53. No abstract available.

PMID:
4242928

Supplemental Content

Loading ...
Support Center